DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2020
| DUOPHARMA BIOTECH BERHAD |
| Financial Year End | 31 Dec 2020 |
| Quarter | 4 Qtr |
| Quarterly report for the financial period ended | 31 Dec 2020 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
31 Dec 2020
|
31 Dec 2019
|
31 Dec 2020
|
31 Dec 2019
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
134,086
|
137,755
|
569,902
|
576,462
|
| 2 | Profit/(loss) before tax |
20,471
|
13,939
|
76,157
|
70,809
|
| 3 | Profit/(loss) for the period |
16,193
|
12,033
|
58,610
|
55,273
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
16,193
|
12,033
|
58,610
|
55,273
|
| 5 | Basic earnings/(loss) per share (Subunit) |
2.29
|
1.76
|
8.46
|
8.25
|
| 6 | Proposed/Declared dividend per share (Subunit) |
6.00
|
5.00
|
6.50
|
6.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.9100
|
0.7700
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 22 Feb 2021 |
| Category | Financial Results |
| Reference Number | FRA-11022021-00004 |